BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11790172)

  • 1. Clinical and serological transition from pemphigus vulgaris to pemphigus foliaceus demonstrated by desmoglein ELISA system.
    Tsuji Y; Kawashima T; Yokota K; Tateish Y; Tomita Y; Matsumura T; Shimizu H
    Arch Dermatol; 2002 Jan; 138(1):95-6. PubMed ID: 11790172
    [No Abstract]   [Full Text] [Related]  

  • 2. Three cases of transition from pemphigus vulgaris to pemphigus foliaceus confirmed by desmoglein ELISA.
    Ng PP; Thng ST
    Dermatology; 2005; 210(4):319-21. PubMed ID: 15942219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
    Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T
    Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological tests: Anti desmoglein 1 and 3 antibody].
    Amagai M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():571-4. PubMed ID: 16111335
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris.
    Zagorodniuk I; Weltfriend S; Shtruminger L; Sprecher E; Kogan O; Pollack S; Bergman R
    Int J Dermatol; 2005 Jul; 44(7):541-4. PubMed ID: 15985020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3.
    Harman KE; Gratian MJ; Seed PT; Bhogal BS; Challacombe SJ; Black MM
    Clin Exp Dermatol; 2000 May; 25(3):236-40. PubMed ID: 10844505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.
    Mortazavi H; Shahdi M; Amirzargar AA; Naraghi ZS; Valikhani M; Daneshpazhooh M; Vasheghani-Farahani A; Sedaghat M; Chams-Davatchi C
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):53-6. PubMed ID: 19279360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemphigus herpetiformis with an autoimmune response to recombinant desmoglein 1.
    Seitz CS; Staegemeir E; Amagai M; Rose C; Bröcker EB; Zillikens D
    Br J Dermatol; 1999 Aug; 141(2):354-5. PubMed ID: 10469475
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymoma with pemphigus foliaceus.
    Takeshita K; Amano M; Shimizu T; Oyamada Y; Abiko T; Kobayashi K; Futei Y; Amagai M; Kuramochi S; Asano K; Yamaguchi K
    Intern Med; 2000 Sep; 39(9):742-7. PubMed ID: 10969907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.
    Cheng SW; Kobayashi M; Kinoshita-Kuroda K; Tanikawa A; Amagai M; Nishikawa T
    Br J Dermatol; 2002 Aug; 147(2):261-5. PubMed ID: 12174096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection and successful management of oral pemphigus vulgaris: a case report.
    Endo H; Rees TD; Matsue M; Kuyama K; Nakadai M; Yamamoto H
    J Periodontol; 2005 Jan; 76(1):154-60. PubMed ID: 15830652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number II. Pemphigus vulgaris.
    Black M; Mignogna MD; Scully C
    Oral Dis; 2005 May; 11(3):119-30. PubMed ID: 15888101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.
    Ishii K; Amagai M; Hall RP; Hashimoto T; Takayanagi A; Gamou S; Shimizu N; Nishikawa T
    J Immunol; 1997 Aug; 159(4):2010-7. PubMed ID: 9257868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune pemphigus. A distinct staining pattern with an anti-desmoglein antibody.
    Carlotti A; Balaton AJ; de Muret A; Vaillant L; Wechsler J; Villela M
    Arch Dermatol; 1993 May; 129(5):596-9. PubMed ID: 8481021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Developments on paraneoplasic pemphigus].
    Caneppèle-Carel S; Mazereeuw-Hautier J; Bazex J
    Ann Dermatol Venereol; 2001 Apr; 128(4):561-6. PubMed ID: 11395661
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
    Hashimoto T; Amagai M; Garrod DR; Nishikawa T
    Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus.
    Ishii K; Amagai M; Komai A; Ebihara T; Chorzelski TP; Jablonska S; Ohya K; Nishikawa T; Hashimoto T
    Arch Dermatol; 1999 Aug; 135(8):943-7. PubMed ID: 10456343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition of pemphigus vulgaris into pemphigus foliaceus confirmed by antidesmoglein ELISA profile.
    Tóth GG; Pas HH; Jonkman MF
    Int J Dermatol; 2002 Aug; 41(8):525-7. PubMed ID: 12207776
    [No Abstract]   [Full Text] [Related]  

  • 19. Altered immunohistochemical staining for desmoglein in skin biopsies in canine pemphigus foliaceus.
    Steeves EB; Chelack BJ; Clark EG; Haines DM
    J Vet Diagn Invest; 2002 Jan; 14(1):53-6. PubMed ID: 12680644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic features of pemphigus vulgaris in patients with pemphigus foliaceus: detection of both autoantibodies, long-term follow-up and treatment responses.
    Sami N; Bhol KC; Ahmed AR
    Clin Exp Immunol; 2001 Sep; 125(3):492-8. PubMed ID: 11531959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.